Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 21, 2022, IGM Biosciences, Inc. (the "Company") held its 2022 annual meeting of stockholders (the "Annual Meeting"). Of the 27,398,206 shares of common stock outstanding of April 25, 2022, the record date for the Annual Meeting, 25,692,481 shares of common stock were present in person (including virtually) or by proxy at the Annual Meeting, representing approximately 93.8% of the shares entitled to vote at the Annual Meeting and constituting a quorum for the transaction of business. The proposals voted upon at the meeting and the final voting results with respect to each proposal are as set forth below.

Proposal 1: Election of Directors

Each of the following nominees was elected to serve as a Class III director to serve until the Company's 2025 annual meeting of stockholders or until his or her respective successor is duly elected and qualified.



Nominee                     For           Withheld        Broker Non-Votes
Felix J. Baker, Ph.D.     21,762,597       2,610,258              1,319,626
Michael Lee               23,201,507       1,171,348              1,319,626
Fred Schwarzer            23,348,728       1,024,127              1,319,626

Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm

The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2021 was ratified.



   For       Against   Abstain   Broker Non-Votes
25,688,574    3,466      411           N/A


--------------------------------------------------------------------------------

© Edgar Online, source Glimpses